...
首页> 外文期刊>Clinical & developmental immunology. >Model for Vaccine Design by Prediction of B-Epitopes of IEDB Given Perturbations in Peptide Sequence, In Vivo Process, Experimental Techniques, and Source or Host Organisms
【24h】

Model for Vaccine Design by Prediction of B-Epitopes of IEDB Given Perturbations in Peptide Sequence, In Vivo Process, Experimental Techniques, and Source or Host Organisms

机译:通过在肽序列,体内过程,实验技术以及来源或宿主生物的干扰下预测IEDB的B-表位来设计疫苗设计模型

获取原文
获取原文并翻译 | 示例

摘要

Perturbation methods add variation terms to a known experimental solution of one problem to approach a solution for a related problem without known exact solution. One problem of this type in immunology is the prediction of the possible action of epitope of one peptide after a perturbation or variation in the structure of a known peptide and/or other boundary conditions (host organism, biological process, and experimental assay). However, to the best of our knowledge, there are no reports of general-purpose perturbation models to solve this problem. In a recent work, we introduced a new quantitative structure-property relationship theory for the study of perturbations in complex biomolecular systems. In this work, we developed the first model able to classify more than 200,000 cases of perturbations with accuracy, sensitivity, and specificity >90% both in training and validation series. The perturbations include structural changes in >50000 peptides determined in experimental assays with boundary conditions involving >500 source organisms, >50 host organisms, >10 biological process, and >30 experimental techniques. The model may be useful for the prediction of new epitopes or the optimization of known peptides towards computational vaccine design.
机译:摄动方法将变化项添加到一个问题的已知实验解中,从而在没有已知精确解的情况下找到相关问题的解。免疫学中这种类型的一个问题是在已知肽的结构发生扰动或变化和/或其他边界条件(宿主生物,生物学过程和实验分析)后,预测一种肽的表位的可能作用。但是,据我们所知,尚无通用微扰模型可以解决此问题的报道。在最近的工作中,我们引入了一种新的定量结构-性质关系理论,用于研究复杂生物分子系统中的扰动。在这项工作中,我们开发了第一个模型,该模型能够在训练和验证系列中对200,000例扰动案例进行分类,其准确性,敏感性和特异性均> 90%。扰动包括在> 50000个肽段的结构变化,这些变化是在涉及> 500个源生物,> 50个宿主生物,> 10个生物过程和> 30个实验技术的边界条件下进行的。该模型可用于预测新的表位或优化已知肽以用于计算疫苗设计。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号